Molecular characterisation of mixed and dedifferentiated endometrial carcinomas reveals shared pathogenesis and clonal origin

Objectives Mixed carcinoma of the endometrium (MCE) is an epithelial malignancy composed of two or more histological types. The recent WHO classification of MCE differs from its ovarian counterpart: dedifferentiated carcinomas are excluded from MCE, whereas ovarian dedifferentiated carcinomas are considered a special type of mixed carcinoma. However, the genetic basis of MCE remains poorly understood, as studies with comprehensive genomic analyses are scarce. This study aimed to identify genetic alterations involved in the development of MCE and endometrial dedifferentiated carcinomas (EDC) using next-generation sequencing (NGS) data and to determine whether MCE and EDC show distinct pathogenetic features supporting their classification as separate entities. Methods We retrospectively reviewed 1,578 endometrial carcinomas treated at or referred to our institute between January 2017 and December 2025. Mixed carcinomas were identified by morphological examination and immunohistochemistry. NGS using the Oncomine Comprehensive Assay V3 was performed separately on each component of six MCEs. Although EDCs are not classified as mixed carcinomas according to WHO criteria, nine such cases were also analysed for comparison. Results Excluding carcinosarcomas, MCEs accounted for 0.63% (10/1,578) of endometrial carcinomas, while EDCs represented 0.57% (9/1,578). With one exception, all MCEs and EDCs shared at least one identical pathogenic mutation between their components, supporting a clonal relationship. Among MCEs, 60% (6/10) showed mismatch repair deficiency (dMMR) in at least one component, and one case harboured a POLE mutation. Similarly, 89% (8/9) of EDCs were dMMR in at least one component, while one case was POLE -mutated. Both tumour groups frequently harboured alterations in the SWI/SNF and PI3K/AKT pathways, particularly involving ARID1A , PIK3CA , and PTEN . ARID1A mutations were especially frequent in EDCs (7/9, 78%). Conclusion The components of almost all MCE and EDC were clonally related, suggesting development through transdifferentiation or divergent differentiation rather than independent collision. Despite their classification as separate entities in the current WHO system, both tumour types appear to arise predominantly in the setting of dMMR and genomic hypermutability. These findings provide further insight into the molecular pathogenesis of mixed carcinomas of the female genital tract and may contribute to future refinements in their classification.

Authors

Institutions

Publication Details

Journal
Pathology & Oncology Research
Published
2026-11-19
DOI
https://doi.org/10.3389/pore.2026.1612616
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular characterisation of mixed and dedifferentiated endometrial carcinomas reveals shared pathogenesis and clonal origin

Ildikó Vereczkey, Zsombor Melegh, Levente Kuthi, Luca Szalai et al.
Pathology & Oncology Research
Endometrial and Cervical Cancer Treatments
article

Molecular characterisation of mixed and dedifferentiated endometrial carcinomas reveals shared pathogenesis and clonal origin

Ildikó Vereczkey, Zsombor Melegh, Levente Kuthi, Luca Szalai, Erika Tóth, Judit Betenbuk, Andrea Simon
article en

Abstract

Objectives Mixed carcinoma of the endometrium (MCE) is an epithelial malignancy composed of two or more histological types. The recent WHO classification of MCE differs from its ovarian counterpart: dedifferentiated carcinomas are excluded from MCE, whereas ovarian dedifferentiated carcinomas are considered a special type of mixed carcinoma. However, the genetic basis of MCE remains poorly understood, as studies with comprehensive genomic analyses are scarce. This study aimed to identify genetic alterations involved in the development of MCE and endometrial dedifferentiated carcinomas (EDC) using next-generation sequencing (NGS) data and to determine whether MCE and EDC show distinct pathogenetic features supporting their classification as separate entities. Methods We retrospectively reviewed 1,578 endometrial carcinomas treated at or referred to our institute between January 2017 and December 2025. Mixed carcinomas were identified by morphological examination and immunohistochemistry. NGS using the Oncomine Comprehensive Assay V3 was performed separately on each component of six MCEs. Although EDCs are not classified as mixed carcinomas according to WHO criteria, nine such cases were also analysed for comparison. Results Excluding carcinosarcomas, MCEs accounted for 0.63% (10/1,578) of endometrial carcinomas, while EDCs represented 0.57% (9/1,578). With one exception, all MCEs and EDCs shared at least one identical pathogenic mutation between their components, supporting a clonal relationship. Among MCEs, 60% (6/10) showed mismatch repair deficiency (dMMR) in at least one component, and one case harboured a POLE mutation. Similarly, 89% (8/9) of EDCs were dMMR in at least one component, while one case was POLE -mutated. Both tumour groups frequently harboured alterations in the SWI/SNF and PI3K/AKT pathways, particularly involving ARID1A , PIK3CA , and PTEN . ARID1A mutations were especially frequent in EDCs (7/9, 78%). Conclusion The components of almost all MCE and EDC were clonally related, suggesting development through transdifferentiation or divergent differentiation rather than independent collision. Despite their classification as separate entities in the current WHO system, both tumour types appear to arise predominantly in the setting of dMMR and genomic hypermutability. These findings provide further insight into the molecular pathogenesis of mixed carcinomas of the female genital tract and may contribute to future refinements in their classification.

Pathology & Oncology ResearchVol. 32
Semmelweis University (HU), National Institute of Oncology (HU), Hungarian Research Network (HU), HUN-REN Research Centre for Natural Sciences (HU)
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon